62.2 F
New York
Wednesday, September 30, 2020

Monopar Therapeutics Inc. (NASDAQ:MNPR) is Waving the Bear Flag

Must read

Renewed Optimism is Surrounding Corning Incorporated (NYSE:GLW)

Corning Incorporated (GLW) shares are trading at lower $31.97 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

People’s United Financial Inc. (NASDAQ:PBCT) is Gaining Momentum on Earnings Catalyst

People's United Financial Inc. (PBCT) shares are trading at lower $10.17 and the avg recommendation for the stock is Moderate Buy, while the current...

Avalon GloboCare Corp. (NASDAQ:AVCO) Finding Strong Support

Avalon GloboCare Corp. (AVCO) shares are trading at higher $1.47. To add more color to this target, the company’s high over the last year...

Titan Pharmaceuticals Inc. (NASDAQ:TTNP) on the Path to Ruin

Titan Pharmaceuticals Inc. (TTNP) shares are trading at lower $0.17 and the avg recommendation for the stock is Moderate Buy. To add more color...

The Monopar Therapeutics Inc. (MNPR) shares are trading at lower $6.99 and the avg recommendation for the stock is Moderate Buy.

To add more color to this target, the company’s high over the last year is $48.00 and the low is $4.94. Over the last 52 weeks, MNPR is down -85.44% while the S&P 500 is up 1.39%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, MNPR reported a profit of $18000.0. Monopar Therapeutics Inc. also saw revenues increase to $1.46 million. In addition, MNPR has free cash flow of -$2.12 million as of 06-2020. The company’s EBITDA came in at -$1.46 million which compares well with its peers.

MNPR Return on Equity (ROE) is -45.30%, and its Return on Assets is -42.70%. All told, it is clear that, MNPR needs to be on your watchlist.

Find out when MNPR reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. MNPR has a short ratio of 0.75 and outstanding shares of 10.61M.

Company Outlook

MNPR has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 21900.0 and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -0.38. Monopar Therapeutics Inc. MNPR also noted assets of $12.8 million at the end of the last quarter. Investors should also keep an eye on sector updates as MNPR has historically followed its peers on positive news.

All told, Monopar Therapeutics Inc. MNPR has strung together solid data and demonstrated underlying fundamentals. At its current valuation, MNPR represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Monopar Therapeutics Inc. MNPR is now commanding a market cap of 76.47M and a float of 2.22M. MNPR is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of MNPR stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in MNPR, either long or short, and we have not been compensated for this article.

Latest article

Helix Energy Solutions Group Inc. (NYSE:HLX) is Holding Steady

Helix Energy Solutions Group Inc. (HLX) shares are trading at lower $2.43 and the avg recommendation for the stock is Moderate Buy. To add...

Investor Confidence is Rising for Target Corporation (NYSE:TGT)

Target Corporation (TGT) shares are trading at higher $156.94 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Elanco Animal Health Incorporated (NYSE:ELAN) is Gaining Momentum on Earnings Catalyst

Elanco Animal Health Incorporated (ELAN) shares are trading at lower $26.76 and the avg recommendation for the stock is Moderate Buy, while the current...

The Rejuvenation of Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. (CRON) shares are trading at higher $5.05. To add more color to this target, the company’s high over the last year...

F.N.B. Corporation (NYSE:FNB) Recent Earnings Shows Major Concern

F.N.B. Corporation (FNB) shares are trading at lower $6.73 and the avg recommendation for the stock is Strong Buy, while the current analyst price...